Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Ready For More Medtech Market Access Simplifications

Executive Summary

Following the recent news of local trial exemptions for almost 160 types of medical devices and IVDs in China, the China Food and Drug Administration is preparing to introduce more market access regulatory simplifications for medtech companies entering the Chinese market.

Advertisement

Related Content

China Proposes Local Trial Exemptions For Another 130 IVDs, 27 Devices
Third Expedited Approval Pathway Coming To China In January

Topics

Advertisement
UsernamePublicRestriction

Register

MT105132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel